Status:
UNKNOWN
PVF in Decongestion of Heart Failure
Lead Sponsor:
Assiut University
Conditions:
Heart Failure，Congestive
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate PVF alterations in patients with ADHF at arrival and after decongestive treatment
Detailed Description
Hospitalizations from heart failure have been shown to be preceded by a gradual increase in cardiac filling pressures using invasive ambulatory monitoring measurements \[1, 2\]., this technique does n...
Eligibility Criteria
Inclusion
- Age above 18 years.
- Patients presented with acute decompensated heart failure (either de novo HF or chronic decompensated HF) fulfilling the following criteria: new or worsening HF symptoms (including dyspnea, decreased exercise capacity, fatigue, or other volume overload symptoms), physical examination findings compatible with HF (peripheral edema, pulmonary congestion, increased jugular venous pressure or third heart sound)
Exclusion
- age below 18.
- pregnant.
- cardiogenic shock, or hemodynamic instability.
- Patients with previously diagnosed Child-Pugh B or C liver cirrhosis, liver transplant, or ESRD on renal replacement therapy
Key Trial Info
Start Date :
October 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05227872
Start Date
October 30 2021
End Date
December 1 2024
Last Update
February 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt